Fluorescein Angiography of the Fundus with Active Retinopathy of Prematurity (Review)
https://doi.org/10.18008/1816-5095-2018-4-361-365
Abstract
The literature review provides information regarding the use of the fluorescein angiography of the fundus (FFA) in retinopathy of prematurity (ROP). Sanctified security issues FFA treatments in children; the use of FFA in the screening, diagnosis and determining the course of management of patients with ROP, data usage FFA in the assessment of treatment efficacy in ROP, and the role of FFA in detailing clinicalmorphometric classification of ROP. According to the data presented in domestic and foreign literature, the FFA is a highly informative method of research in preterm children with active stages of ROP. It can detect the degree of vascular disorders and prevalence of pathological process, including in cases when pathological changes are still not made available to other ophthalmic research.
About the Authors
A. V. TereshchenkoRussian Federation
MD, Director
Svyatoslav Fedorov str., 5, Kaluga, 248007, Russia
I. G. Trifanenkova
Russian Federation
MD, Deputy Director for Research
Svyatoslav Fedorov str., 5, Kaluga, 248007, Russia
Yu. A. Yudina
Russian Federation
Research assistant
Svyatoslav Fedorov str., 5, Kaluga, 248007, Russia
References
1. Novotny H., Alvis D. A method of photographing fluorescence in circulating blood in the human retina. Circulation. 1961;24:82–86.
2. Кацнельсон Л.А., Лысенко В.С., Балишанская Т.И. Клинический атлас патологии глазного дна. 4-е изд. М.: ГЭОТАР-Медиа, 2008 [Katsnelson L.A., Lysenko V.S., Balishanskaya T.I. Clinical Atlas of fundus pathology. 4th ed. Moscow: GEOTAR-Media, 2008 (In Russ.)].
3. Cantolino S., O’Grady G., Herrera J. et al. Ophthalmoscopic monitoring of oxygen therapy in premature infants. Fluorescein angiography in acute retrolental fibroplasia. Am J Ophthalmol. 1971;72(2):322–331.
4. Flynn J., Cassady J., Essner D. Fluorescein angiography in retrolental fibroplasia: experience from 1969–1977. Ophthalmology. 1979;86(10):1700–1723.
5. O’Grady G., Flynn J., Clarkson J., Clark R. Retrolental fibroplasia: clinical, fluorescein angiographic and pathological correlation. Mod Probl Ophthalmol. 1974;12:144–151.
6. Payne J., Patz A. Fluorescein angiography in retrolental fibroplasia. Int Ophthalmol Clin. 1977;17(2):121–135.
7. Uehara M., Ueno A., Itotagawa S. Fluorescein angiographic studies on retinopathy of prematurity. Nippon Ganka Gakkai Zasshi. 1976:80(10):1204–1215.
8. Wagner R. Fundus fluorescein angiography in retinopathy of prematurity. J Pediatr Ophthalmol Strabismus. 2006:43(2):78.
9. Klufas M., Patel S., Ryan M. et al. Influence of Fluorescein Angiography on the Diagnosis and Management of Retinopathy of Prematurity. Ophthalmology. 2015;122(8):1601–1608. DOI: 10.1016/j.ophtha.2015.04.023
10. Guagliano R., Barillà D., Bertone C. Fluorescein angiography-based diagnosis for retinopathy of prematurity: expert-non expert comparison. Eur J Ophthalmol. 2013;23(6):881–886. DOI: 10.5301/ejo.5000319
11. Azad R., Chandra P., Khan M., Darswal A. Role of intravenous fluorescein angiography in early detection and regression of retinopathy of prematurity. J Pediatr Ophthalmol Strabismus. 2008;45(1):36–39.
12. Purcaro V., Baldascino A., Papacci P. et al. Fluorescein angiography and retinal vascular development in premature infants. J Matern Fetal Neonatal Med. 2012;25(3):53–56. DOI: 10.3109/14767058.2012.712313
13. Zepeda-Romero L., Oregon-Miranda A., Lizarraga-Barrón D. Early retinopathy of prematurity findings identified with fluorescein angiography. Graefes Arch Clin Exp Ophthalmol. 2013;251(9):2093–2097. DOI: 10.1007/s00417-013-2321-8
14. Lepore D., Quinn G., Molle F. et al. Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings. Ophthalmology. 2014;121(11):2212–2219. DOI: 10.1016/j.ophtha.2014.05.015
15. Ng E., Lanigan B., O’Keefe M. Fundus fluorescein angiography in the screening for and management of retinopathy of prematurity. J Pediatr Ophthalmol Strabismus. 2006;43(2):85–90.
16. Lepore D., Molle F., Pagliara M. et al. Atlas of fluorescein angiographic findings in eyes undergoing laser for retinopathy of prematurity. Ophthalmology. 2011;118(1):168–175. DOI: 10.1016/j.ophtha.2010.04.021
17. Nishina S., Yokoi T., Yokoi T. et al. Effect of early vitreous surgery for aggressive posterior retinopathy of prematurity detected by fundus fluorescein angiography. Ophthalmology. 2009;116(12):2442–2447. DOI: 10.1016/j.ophtha.2009.05.011
18. Yokoi T., Yokoi T., Kobayashi Y. et al. Evaluation of scleral buckling for stage 4A retinopathy of prematurity by fluorescein angiography. Am J Ophthalmol. 2009;148(4):544–550. DOI: 10.1016/j.ajo.2009.05.027
19. Henaine-Berra A., Garcia-Aguirre G., Quiroz-Mercado H., Martinez-Castellanos M. Retinal fluorescein angiographic changes following intravitreal anti-VEGF therapy. J AAPOS. 2014;18(2):120–123. DOI: 10.1016/j.jaapos.2013.12.009
20. Park S., Jung H., Heo H. Fluorescein angiography of aggressive posterior retinopathy of prematurity treated with intravitreal anti-VEGF in large preterm babies. Acta Ophthalmol. 2014;92(8):810–813. DOI: 10.1111/aos.12461
21. Tahija S., Hersetyati R., Lam G. et al. Fluorescein angiographic observations of peripheral retinal vessel growth in infants after intravitreal injection of bevacizumab as sole therapy for zone I and posterior zone II retinopathy of prematurity. Br J Ophthalmol. 2014;98(4):507–512. DOI: 10.1136/bjophthalmol-2013-304109.507
22. Hoang Q., Kiernan D., Chau F. et al. Fluorescein angiography of recurrent retinopathy of prematurity after initial intravitreous bevacizumab treatment. Arch Ophthalmol. 2010;128(8):1080–1081. DOI: 10.1001/archophthalmol.2010.145
23. Терещенко А.В., Белый Ю.А., Терещенкова М.С., Трифаненкова И.Г. Классификация задней агрессивной ретинопатии недоношенных. Офтальмохирургия. 2013;2:68–72 [Tereshchenko A.V., Bely Yu.A., Tereshchenkova M.S., Trifanenkova I.G. Classification of posterior aggressive retinopathy of prematurity. Ophthalmosurgery = Oftal’mokhirurgiya. 2013;2:68–72 (In Russ.)].
24. Терещенко А.В., Белый Ю.А., Трифаненкова И.Г. Возможности флюоресцентной ангиографии в диагностике и определении тактики лечения активных стадий ретинопатии недоношенных. Офтальмохирургия. 2014;4:74–78 [Tereshchenko A.V., Bely Yu.A., Trifanenkova I.G. Possibilities of fluorescein angiography in the diagnosis and tactics of the active stages of retinopathy of prematurity treatment. Ophthalmosurgery = Oftal’mokhirurgiya. 2014;4:74–78 (In Russ.)].
25. Терещенко А.В., Белый Ю.А., Трифаненкова И.Г. Флюоресцентная ангиография в диагностике и определении тактики лечения активных стадий ретинопатии недоношенных. Вестник Тамбовского университета. 2014;19(4):1218–1220 [Tereshchenko A.V., Bely Yu.A., Trifanenkova I.G. Fluorescein angiography in the diagnosis and tactics of treatment of the active stages of retinopathy of prematurity. Tambov University Reports = Vestnik Tambovskogo Universiteta. 2014;19(4):1218–1220 (In Russ.)].
26. Трифаненкова И.Г., Терещенко А.В., Белый Ю.А. Флюоресцентная ангиография в детализации клинико-морфометрической классификации активных стадий ретинопатии недоношенных. Современные технологии в офтальмологии. 2016;1(1):222–225 [Trifanenkova I.G., Tereshchenko A.V., Bely Yu.A. Fluorescein angiography in detailing the clinical and morphometric classification of prematurity retinopathy active stages. Modern Technologies in Ophthalmology = Sovremennye tekhnologii v oftal’mologii. 2016;1(1):222–225 (In Russ.)].
27. Трифаненкова И.Г., Терещенко А.В., Белый Ю.А. Флюоресцентно-ангиографические особенности активных стадий ретинопатии недоношенных. Точка зрения: Восток-Запад. 2016;1:168–171 [Trifanenkova I.G., Tereshchenko A.V., Bely Yu.A. Fluorescent-angiographic features of the active stages of retinopathy of prematurity. Viewpoint: East-West = Tochka zreniya: Vostok-Zapad. 2016;1:168–171 (In Russ.)].
Review
For citations:
Tereshchenko A.V., Trifanenkova I.G., Yudina Yu.A. Fluorescein Angiography of the Fundus with Active Retinopathy of Prematurity (Review). Ophthalmology in Russia. 2018;15(4):361-365. (In Russ.) https://doi.org/10.18008/1816-5095-2018-4-361-365